✦ LIBER ✦

Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia

✍ Scribed by He, X-Y; Pohlman, B; Lichtin, A; Rybicki, L; Kalaycio, M

Book ID: 110055493
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 126 KB
Volume: 17
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2402955

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of de novo acute myelogenous l

Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: Effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts

✍ Valent, Peter ;Sillaber, Christian ;Geissler, Klaus ;Andreeff, Michael ;Tafuri, 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

GM-CSF is a major regulator of myelopoiesis. Recombinant human GM-CSF (250 micrograms/m2 per day i.v.) was used prior to chemotherapy ("3 + 7" scheme) to recruit leukemic blasts in vivo (de novo AML patients, n = 20) into the chemotherapy sensitive phases of the cell cycle. The stimulatory effect of

Effect of priming with granulocyte–macro

Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

✍ Thomas, X; Raffoux, E; Botton, S de; Pautas, C; Arnaud, P; de Revel, T; Reman, O 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 162 KB

Intensive chemotherapy with idarubicin,

Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia

✍ Gardin, C; Chaibi, P; de Revel, T; Rousselot, P; Turlure, P; Micléa, J M; Nédell 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 78 KB